Progress Path & Future Outlook
I think if you are prepared to accept what Onsor has stated above about the development timeline for their AKIDA powered NEXA glasses for epilepsy you will be able to answer your own question about the absence of revenue.2021Phase 1.0
Research collaboration with Sultan Qaboos University (SQU) and Intel Neuromorphic Research Community (INRC).
2022Phase 2.0
Identification of potential applications for the technology and the discovery of "epilepsy prediction" as a primary application, marking the official start of the project.
2023Phase 3.5
Preparation of documentation for patent application.
Phase 3.0
Preliminary results from the research emerge.
2024Phase 4.5
Establishment of strategic partnerships.
Submission of the patent application and initiation of the patent examination process.
Phase 4.0
Development of the initial product and creation of an integrated solution.
2025Phase 5.5
Commencement of clinical trials.
Development of a supportive chip for neural computing technology.
Ongoing improvements and development.
Phase 5.0
Approval of the patent.
Publication of the scientific paper.
...2026Phase 7.0
Final product launch.
My opinion only DYOR
Fact Finder
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $435.4M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 22.0¢ | 21.0¢ | $1.041M | 4.863M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 46 | 5101638 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 274006 | 6 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| BRN (ASX) Chart |